[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Letters to the Editor
October 1999

Clozapine Plus Lamotrigine in Treatment-Resistant Schizophrenia

Arch Gen Psychiatry. 1999;56(10):950. doi:10.1001/archpsyc.56.10.950

Clozapine is the only antipsychotic agent with proven efficacy in treatment-resistant schizophrenia1; however, a substantial minority of patients fail to respond or have only a partial response to clozapine, leading clinicians to search for potential augmentation strategies to improve outcomes. To date, these augmentation strategies with clozapine have generally been disappointing.

First Page Preview View Large
First page PDF preview
First page PDF preview